Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Mar-23 6:07 PM View:  | Pyxis Oncology, Inc. (PYXS) | 17-Mar-23 | Private Purchase | 1,811,590 | $2.76 | $5,000,000.00 | 35% 5.22M to 7.03M | |
| 22-Dec-20 5:58 PM View: | Bioatla, Inc. (BCAB) | 18-Dec-20 | Conversion | 2,238,090 | -- | -- | 100% 0 to 2.24M | |
| 16-Nov-20 5:23 PM View: | Viatris Inc (VTRS) | 16-Nov-20 | Disposition (other) | 689,873,984 | -- | -- | (100%) 689.87M to 0 | |
| 16-Nov-20 5:23 PM View: | Viatris Inc (VTRS) | 13-Nov-20 | Acquisition (other) | 689,873,984 | -- | -- | 538964000% 0 to 689.87M | |
| 29-Oct-20 5:44 PM View: | Cerevel Therapeutics Holdin... (CERE) | 27-Oct-20 | Purchase | 1,200,000 | $10.00 | $12,000,000.00 | 5% 26.15M to 27.35M | |
| 04-Jun-20 4:25 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Jun-20 | Market Sale | 370,000 | $40.18 | $14,866,600.00 | (11%) 3.25M to 2.88M | 27% |
| 16-Mar-20 7:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion | 76,003 | -- | -- | 100% 0 to 76.0K | |
| 16-Mar-20 7:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion | 1,169,220 | -- | -- | 1538% 76.0K to 1.25M | |
| 16-Mar-20 7:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Purchase Duplicate | 312,500 | $16.00 | $5,000,000.00 | 25% 1.25M to 1.56M | |
| 19-Sep-19 4:19 PM View: | Springworks Therapeutics, I... (SWTX) | 17-Sep-19 | Conversion | 4,543,850 | -- | -- | 100% 0 to 4.54M | |
| 19-Sep-19 4:19 PM View: | Springworks Therapeutics, I... (SWTX) | 17-Sep-19 | Purchase | 50,000 | $18.00 | $900,000.00 | 1% 4.54M to 4.59M | |
| 14-May-19 7:34 AM View: | Quince Therapeutics, Inc. (QNCX) | 13-May-19 | Conversion | 3,199,970 | -- | -- | 100% 0 to 3.2M | |
| 14-May-19 7:34 AM View: | Quince Therapeutics, Inc. (QNCX) | 13-May-19 | Purchase | 50,000 | $17.00 | $850,000.00 | 2% 3.2M to 3.25M | |
| 16-Nov-18 4:50 PM View: | ICU Medical Inc. (ICUI) | 15-Nov-18 | Market Sale | 2,500,000 | $209.25 | $523,124,992.00 | (100%) 2.5M to 0 | (1%) |
| 17-Oct-18 5:17 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Conversion | 21,976,500 | -- | -- | 100% 0 to 21.98M | |
| 17-Oct-18 5:17 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Purchase | 55,556 | $18.00 | $1,000,010.00 | < 1% 21.98M to 22.03M | |
| 15-Aug-18 4:33 PM View: | ICU Medical Inc. (ICUI) | 13-Aug-18 | Market Sale | 700,000 | $284.35 | $199,044,992.00 | (22%) 3.2M to 2.5M | 26% |
| 10-Oct-17 4:22 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 10-Oct-17 | Conversion | 1,387,640 | -- | -- | 100% 0 to 1.39M | |
| 10-Oct-17 4:22 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 10-Oct-17 | Private Purchase | 40,000 | $17.00 | $680,000.00 | 3% 1.39M to 1.43M | |
| 07-Oct-15 5:42 PM View: | Synlogic, Inc. (SYBX) | 06-Oct-15 | Acquisition (other) | 235,855 | $7.00 | $1,650,980.00 | 15% 1.54M to 1.78M | |
| 07-Oct-15 5:42 PM View: | Synlogic, Inc. (SYBX) | 06-Oct-15 | Purchase | 714,285 | $7.00 | $5,000,000.00 | 40% 1.78M to 2.49M | |
| 07-Oct-15 5:42 PM View: | Synlogic, Inc. (SYBX) | 05-Oct-15 | Conversion | 1,539,220 | -- | -- | 100% 0 to 1.54M | |
| 12-Aug-15 4:30 PM View: | Neurogene Inc. (NGNE) | 10-Aug-15 | Market Sale | 259,927 | $26.47 | $6,880,300.00 | (21%) 1.24M to 975.4K | 58% |
| 14-Mar-14 3:27 PM View: | Neurogene Inc. (NGNE) | 12-Mar-14 | Conversion | 962,603 | -- | -- | 100% 0 to 962.6K | |
| 14-Mar-14 3:27 PM View: | Neurogene Inc. (NGNE) | 12-Mar-14 | Purchase | 272,727 | $11.00 | $3,000,000.00 | 28% 962.6K to 1.24M | |
| 20-Feb-14 2:51 PM View: | Flexion Therapeutics, Inc. (FLXN) | 18-Feb-14 | Conversion | 1,687,250 | -- | -- | 100% 0 to 1.69M | |
| 06-Feb-14 3:53 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 04-Feb-14 | Conversion | 1,567,540 | $0.12 | $185,160.00 | 100% 0 to 1.57M | |
| 06-Feb-14 3:53 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 04-Feb-14 | Purchase | 227,261 | $8.00 | $1,818,090.00 | 14% 1.57M to 1.79M | |
| 26-Jun-13 5:17 PM View: | Zoetis Inc. (ZTS) | 24-Jun-13 | Conversion | 400,984,992 | -- | -- | 100% 0 to 400.98M | |
| 26-Jun-13 5:17 PM View: | Zoetis Inc. (ZTS) | 24-Jun-13 | Disposition (other) | 400,984,992 | -- | -- | (100%) 400.98M to 0 | |
| 08-Feb-13 4:19 PM View: | Zoetis Inc. (ZTS) | 06-Feb-13 | Conversion | 12,915,000 | -- | -- | 15% 86.1M to 99.02M | |
| 08-Feb-13 4:19 PM View: | Zoetis Inc. (ZTS) | 06-Feb-13 | Sale | 99,015,000 | -- | -- | (100%) 99.02M to 0 | |
| 02-Nov-11 7:16 PM View: | ICAgen Inc. (ICGN) | 27-Oct-11 | Market Purchase | 2,743,270 | $6.00 | $16,459,600.00 | (100%) (-2.74M) to 100 | (< 1%) |
| 20-Sep-11 3:06 PM View: | ICAgen Inc. (ICGN) | 19-Sep-11 | Market Purchase | 61,083 | $6.00 | $366,498.00 | < 1% 6.4M to 6.46M | (< 1%) |
| 20-Sep-11 3:06 PM View: | ICAgen Inc. (ICGN) | 16-Sep-11 | Market Purchase | 5,536 | $6.00 | $33,216.00 | < 1% 6.39M to 6.4M | (< 1%) |
| 16-Sep-11 6:01 PM View: | ICAgen Inc. (ICGN) | 15-Sep-11 | Market Purchase | 232,203 | $6.00 | $1,393,220.00 | 4% 6.16M to 6.39M | < 1% |
| 14-Sep-11 7:25 PM View: | ICAgen Inc. (ICGN) | 12-Sep-11 | Market Purchase | 422,023 | $6.00 | $2,532,140.00 | 7% 5.74M to 6.16M | (< 1%) |
| 12-Sep-11 1:27 PM View: | ICAgen Inc. (ICGN) | 09-Sep-11 | Market Purchase | 60,121 | $6.00 | $360,726.00 | 1% 5.68M to 5.74M | < 1% |
| 12-Sep-11 1:27 PM View: | ICAgen Inc. (ICGN) | 08-Sep-11 | Market Purchase | 493 | $6.00 | $2,958.00 | < 1% 5.68M to 5.68M | < 1% |
| 07-Sep-11 6:59 PM View: | ICAgen Inc. (ICGN) | 02-Sep-11 | Market Purchase | 4,617,040 | $6.00 | $27,702,300.00 | 433% 1.07M to 5.68M | (< 1%) |
| 15-Apr-08 8:40 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 14-Apr-08 | Market Purchase | 1,232,410 | $2.35 | $2,896,170.00 | 2% 67.84M to 69.08M | (< 1%) |
| 15-Apr-08 8:40 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 11-Apr-08 | Market Purchase | 155,499 | $2.35 | $365,423.00 | < 1% 67.69M to 67.84M | (< 1%) |
| 11-Apr-08 3:57 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 10-Apr-08 | Market Purchase | 210,794 | $2.35 | $495,366.00 | < 1% 67.48M to 67.69M | (< 1%) |
| 11-Apr-08 3:57 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 09-Apr-08 | Market Purchase | 12,628 | $2.35 | $29,675.80 | < 1% 67.47M to 67.48M | (< 1%) |
| 09-Apr-08 4:37 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 08-Apr-08 | Market Purchase | 29,407 | $2.35 | $69,106.40 | < 1% 67.44M to 67.47M | (< 1%) |
| 09-Apr-08 4:37 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 07-Apr-08 | Market Purchase | 2,203,420 | $2.35 | $5,178,040.00 | 3% 65.23M to 67.44M | (< 1%) |
| 07-Apr-08 6:28 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 04-Apr-08 | Market Purchase | 576,170 | $2.35 | $1,354,000.00 | < 1% 64.66M to 65.23M | (< 1%) |
| 07-Apr-08 6:28 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 03-Apr-08 | Market Purchase | 1,809,660 | $2.35 | $4,252,710.00 | 3% 62.85M to 64.66M | (< 1%) |
| 03-Apr-08 7:09 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 02-Apr-08 | Market Purchase | 6,002 | $2.35 | $14,104.70 | < 1% 70.41M to 70.42M | (< 1%) |
| 03-Apr-08 7:09 PM View: | Encysive Pharmaceuticals Inc (ENCYD.PK) | 01-Apr-08 | Market Purchase | 175,907 | $2.35 | $413,381.00 | < 1% 70.24M to 70.41M | (< 1%) |